Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYH2072 in Uncontrolled Hypertension
NCT07911735Phase 2Not yet recruiting
- Sponsor
- InnovStone Therapeutics
- Start
- Dec 2026
- Primary completion
- Jul 2027
01
Overview
A Phase 2 trial of SYH2072 in hypertension (HTN), resistant hypertension (RH), sponsored by InnovStone Therapeutics. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
SYH2072
03
Conditions
hypertension (HTN)resistant hypertension (RH)
Beyond the preview
Go deeper on NCT07911735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07911735.